CD40 Ligand-Expressing Tumor Cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD40 Ligand-Expressing Tumor Cells, covering 2016-02-08 to 2016-02-08. Get the full timeline:
Most recent: Clinical Trial Update: Treatment of B-CLL With Autologous IL2 and CD40 Ligand-Expressing Tumor Cells + Lenalidomide [Phase 1]